ADC Therapeutics amends financing deal, reducing change of control payment Feb 23, 2026 07:15AM
RBC Capital on ADC Therapeutics (ADCT): 'We think the downside is unwarranted and would be buyers on weakness' Dec 3, 2025 01:43PM
Guggenheim Reiterates Buy Rating on ADC Therapeutics (ADCT) Nov 12, 2025 06:47AM
ADC Therapeutics SA (ADCT) Tops Q3 EPS by 17c Nov 10, 2025 07:31AM
ADC Therapeutics (ADCT) PT Lowered to $7 at H.C. Wainwright Oct 16, 2025 06:44AM


Oct 1, 2025 06:54AM H.C. Wainwright Reiterates Buy Rating on ADC Therapeutics (ADCT)
Aug 12, 2025 07:33AM ADC Therapeutics SA (ADCT) Tops Q2 EPS by 14c
Jun 20, 2025 09:50AM ADC Therapeutics (ADCT) PT Lowered to $5 at RBC Capital
Jun 16, 2025 07:15AM ADC Therapeutics SA (ADCT) Announces Updated Data from ZYNLONTA Investigator-Initiated Trial R/R Marginal Zone Lymphoma
Jun 13, 2025 07:16AM ADC Therapeutics (ADCT) PT Raised to $10 at Guggenheim
Jun 12, 2025 06:46AM ADC Therapeutics SA (ADCT) Prices $100M Share Offering at $3.53/sh
Jun 12, 2025 06:30AM ADC Therapeutics SA (ADCT) Announces Updated Data from LOTIS-7 Clinical Trial
May 14, 2025 04:36PM ADC Therapeutics SA (ADCT) Tops Q1 EPS by 18c
May 14, 2025 07:46AM ADC Therapeutics SA (ADCT) Announces Presentation of LOTIS-7 Clinical Trial Data
Apr 12, 2025 04:00AM Biotech sector Q1 earnings preview from RBC Capital Markets
Mar 31, 2025 06:54AM ADC Therapeutics (ADCT) PT Lowered to $7 at Guggenheim
Mar 28, 2025 10:41AM RBC Capital on ADC Therapeutics (ADCT): 'A Critical Year Ahead for Zynlonta Expansion De-Risking'
Mar 27, 2025 07:37AM ADC Therapeutics SA (ADCT) Tops Q4 EPS by 18c
Feb 24, 2025 06:52AM ADC Therapeutics (ADCT) PT Raised to $8 at Stephens
Jan 6, 2025 07:10AM H.C. Wainwright Reiterates Buy Rating on ADC Therapeutics (ADCT)
Dec 11, 2024 07:31AM ADC Therapeutics (ADCT) Announces Positive Initial Data from LOTIS-7 Clinical Trial Evaluating ZYNLONTA in Combination with Bispecific Antibody in Patients with Relapsed/Refractory Diffuse Large B-cel
Nov 7, 2024 07:33AM ADC Therapeutics SA (ADCT) Tops Q3 EPS by 10c
Aug 6, 2024 04:29PM ADC Therapeutics SA (ADCT) Files $300M Mixed Shelf
Jun 27, 2024 07:15AM ADC Therapeutics (ADCT) to Join Russell 2000 and Russell 3000 Indexes